Emily R. Gordon

655 total citations
42 papers, 289 citations indexed

About

Emily R. Gordon is a scholar working on Molecular Biology, Oncology and Dermatology. According to data from OpenAlex, Emily R. Gordon has authored 42 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Dermatology. Recurrent topics in Emily R. Gordon's work include Cutaneous lymphoproliferative disorders research (7 papers), Cutaneous Melanoma Detection and Management (6 papers) and Autoimmune Bullous Skin Diseases (4 papers). Emily R. Gordon is often cited by papers focused on Cutaneous lymphoproliferative disorders research (7 papers), Cutaneous Melanoma Detection and Management (6 papers) and Autoimmune Bullous Skin Diseases (4 papers). Emily R. Gordon collaborates with scholars based in United States, United Kingdom and Canada. Emily R. Gordon's co-authors include Sara J. Cooper, Chunhua Weng, Megan H. Trager, Ryne C. Ramaker, Faramarz H. Samie, R Myers, Larisa J. Geskin, Anita B. Hjelmeland, Despina Kontos and Lydia S. Dugdale and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Emily R. Gordon

28 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily R. Gordon United States 10 141 62 59 39 33 42 289
Donovan Watza United States 9 167 1.2× 48 0.8× 46 0.8× 18 0.5× 52 1.6× 17 331
Irineu Illa-Bochaca United States 12 121 0.9× 190 3.1× 74 1.3× 52 1.3× 26 0.8× 22 371
Manuela Benary Germany 8 71 0.5× 32 0.5× 46 0.8× 75 1.9× 14 0.4× 16 245
Suji Lee South Korea 9 104 0.7× 44 0.7× 57 1.0× 8 0.2× 14 0.4× 38 263
Mame Daro Faye Canada 12 218 1.5× 48 0.8× 68 1.2× 8 0.2× 28 0.8× 22 365
Koji Horie Japan 10 117 0.8× 78 1.3× 15 0.3× 51 1.3× 20 0.6× 16 333
Μαρία Παναγοπούλου Greece 12 256 1.8× 57 0.9× 155 2.6× 26 0.7× 48 1.5× 29 401
Xingxin Pan United States 7 207 1.5× 16 0.3× 53 0.9× 20 0.5× 9 0.3× 13 276
Sam Polesie Sweden 12 122 0.9× 161 2.6× 8 0.1× 93 2.4× 28 0.8× 45 471
Erica K. Barnell United States 10 107 0.8× 108 1.7× 82 1.4× 14 0.4× 44 1.3× 25 296

Countries citing papers authored by Emily R. Gordon

Since Specialization
Citations

This map shows the geographic impact of Emily R. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily R. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily R. Gordon more than expected).

Fields of papers citing papers by Emily R. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily R. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily R. Gordon. The network helps show where Emily R. Gordon may publish in the future.

Co-authorship network of co-authors of Emily R. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Emily R. Gordon. A scholar is included among the top collaborators of Emily R. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily R. Gordon. Emily R. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gordon, Emily R., et al.. (2025). Negative descriptors in electronic health records of patients with diabetes. Journal of the American Medical Informatics Association. 32(10). 1589–1597.
2.
3.
Park, Jimyung, Casey Ta, Betina Idnay, et al.. (2024). Criteria2Query 3.0: Leveraging generative large language models for clinical trial eligibility query generation. Journal of Biomedical Informatics. 154. 104649–104649. 17 indexed citations
4.
Gordon, Emily R., Megan H. Trager, Faramarz H. Samie, & Tatyana R. Humphreys. (2024). Part 2: Management of intraoperative and perioperative bleeding. Journal of the American Academy of Dermatology. 92(3). 407–416.
5.
Gordon, Emily R., et al.. (2024). Exploring Cutaneous Lymphoproliferative Disorders in the Wake of COVID-19 Vaccination. SHILAP Revista de lepidopterología. 4(3). e367–e367.
6.
Gordon, Emily R., Megan H. Trager, Connor J. Stonesifer, et al.. (2024). Maintenance therapy for CTCL: importance for prevention of disease progression. Leukemia & lymphoma. 65(12). 1883–1890.
7.
Queen, Dawn, Megan H. Trager, Weijia Fan, Emily R. Gordon, & Faramarz H. Samie. (2024). Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ. Archives of Dermatological Research. 316(6). 220–220. 1 indexed citations
8.
Trager, Megan H., Emily R. Gordon, Tatyana R. Humphreys, & Faramarz H. Samie. (2024). Part 1: Management of antithrombotic medications in dermatologic surgery. Journal of the American Academy of Dermatology. 92(3). 389–404. 1 indexed citations
9.
Spotnitz, Henry M., et al.. (2024). A Survey of Clinicians' Views of the Utility of Large Language Models. Applied Clinical Informatics. 15(2). 306–312. 16 indexed citations
10.
Trager, Megan H., et al.. (2024). A unique case of paraneoplastic lymphomatoid Papuloerythroderma of Ofuji with atypical clinical features. JAAD Case Reports. 50. 102–107.
11.
12.
Xu, Hongyuan, et al.. (2024). Elevated SLC7A2 expression is associated with an abnormal neuroinflammatory response and nitrosative stress in Huntington’s disease. Journal of Neuroinflammation. 21(1). 59–59. 4 indexed citations
13.
14.
Gordon, Emily R., et al.. (2023). Genomic analysis reveals HDAC1 regulates clinically relevant transcriptional programs in Pancreatic cancer. BMC Cancer. 23(1). 1137–1137. 6 indexed citations
15.
Gordon, Emily R., et al.. (2023). An update on methods for detection of prognostic and predictive biomarkers in melanoma. Frontiers in Cell and Developmental Biology. 11. 1290696–1290696. 8 indexed citations
16.
Jones, Amber B., Emily R. Gordon, Christopher D. Willey, et al.. (2023). Carmofur prevents cell cycle progression by reducing E2F8 transcription in temozolomide-resistant glioblastoma cells. Cell Death Discovery. 9(1). 451–451. 6 indexed citations
17.
Jones, Amber B., Emily R. Gordon, David K. Crossman, et al.. (2022). Targeting Acid Ceramidase Inhibits Glioblastoma Cell Migration through Decreased AKT Signaling. Cells. 11(12). 1873–1873. 13 indexed citations
18.
Gordon, Emily R., Dorota Klepacki, Nora Vázquez‐Laslop, et al.. (2021). Structural basis for the tryptophan sensitivity of TnaC-mediated ribosome stalling. Nature Communications. 12(1). 5340–5340. 32 indexed citations
19.
Gordon, Emily R., Sara J. Cooper, Matthew Redmann, et al.. (2021). Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells. PLoS ONE. 16(5). e0250649–e0250649. 8 indexed citations
20.
Ramaker, Ryne C., Emily R. Gordon, & Sara J. Cooper. (2017). R2DGC: threshold-free peak alignment and identification for 2D gas chromatography-mass spectrometry in R. Bioinformatics. 34(10). 1789–1791. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donovan Watza Breakdown of academic impact, for papers by Irineu Illa-Bochaca Breakdown of academic impact, for papers by Manuela Benary Breakdown of academic impact, for papers by Suji Lee Breakdown of academic impact, for papers by Mame Daro Faye Breakdown of academic impact, for papers by Koji Horie Breakdown of academic impact, for papers by Μαρία Παναγοπούλου Breakdown of academic impact, for papers by Xingxin Pan Breakdown of academic impact, for papers by Sam Polesie Breakdown of academic impact, for papers by Erica K. Barnell
Rankless by CCL
2026